AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...

Google DeepMind releases AlphaFold 3's source code to academics, marking a significant advance in AI-powered molecular biology and drug discovery, while balancing open science with commercial ...

Former President Donald Trump has boasted in recent months about “Right To Try,” a law he signed in 2018. It’s aimed at ...

The contents section serves as a navigational ... products approved or submitted for approval under an abbreviated new drug application (ANDA) depends on the labeling of the listed drug referenced ...

High-throughput screening (HTS) enables the rapid testing of numerous compounds against biological targets. By automating and ...

The contents section serves as a navigational ... 2006 Voluntarily at any time a Includes new drug applications, biological license applications, and efficacy supplements.

FDA sets PDUFA Action Date of June 28, 2025 ...

This article discusses continuous manufacturing and the increasing interest of this over traditional batch processing for ...

5.2 The impugned goods are for testing of food and not for diagnostic purposes of human beings (including animals). Main ...

Henlius and Organon announced US FDA has accepted the Biologics License Application (BLA) for HLX14, biosimilar candidate of ...

Qeadan’s team claims their findings make a case for “exploring existing drugs for new applications.” ©2024 New York Daily ...

We recently compiled a list of the 20 AI News Investors Should Not Miss. In this article, we are going to take a look at ...